Dipyridamole
NDC Package 0054-0435-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dipyridamole is a medication used in combination with "blood thinners" such as warfarin to keep clots from forming after heart valve replacements. Marketed by West-ward Pharmaceuticals Corp., this product is identified by NDC 0054-0435 and is authorized under FDA application NDA012836.

Identification & Billing

NDC Package Code
0054-0435-25
Package Description
100 TABLET in 1 BOTTLE
Product Code
0054-0435
11-Digit Billing Format
00054043525
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Dipyridamole
Dosage Form
-
Usage Information
This medication is used in combination with "blood thinners" such as warfarin to keep clots from forming after heart valve replacements. Clots are a serious complication that can cause strokes, heart attacks, or blocked blood vessels in the lungs (pulmonary embolisms). Dipyridamole is an antiplatelet drug. It helps to keep blood flowing by stopping platelets from clumping together and by keeping heart blood vessels open.

Regulatory & Marketing

Labeler Name
West-ward Pharmaceuticals Corp.
FDA Application #
NDA012836
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
02-15-2012
End Marketing Date
07-31-2018
Listing Expiration
07-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0054-0435-25 identifies a specific commercial package of 100 tablet in 1 bottle of Dipyridamole, labeled by West-ward Pharmaceuticals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by West-ward Pharmaceuticals Corp. on February 15, 2012. The current certification is valid through July 31, 2018.

What are the primary indications for this medication?

This medication is used in combination with "blood thinners" such as warfarin to keep clots from forming after heart valve replacements. Clots are a serious complication that can cause strokes, heart attacks, or blocked blood vessels in the lungs (pulmonary embolisms). Dipyridamole is an antiplatelet drug. It helps to keep blood flowing by stopping platelets from clumping together and by keeping heart blood vessels open.

How is this West-ward Pharmaceuticals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00054043525. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0054-0435-25
11-Digit CMS (5-4-2)
00054-0435-25

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.